We are live on ! Find out more
CIBC Private Wealth Group

CIBC Private Wealth Group Portfolio holdings

AUM $59.2B
1-Year Est. Return 20.62%
This Fund
S&P 500
This Quarter Est. Return
+9.83%
1 Year Est. Return
+20.62%
3 Year Est. Return
+88.19%
5 Year Est. Return
+111.32%
10 Year Est. Return
+389.71%
AUM
$43.5B
AUM Growth
+$3.82B
Cap. Flow
+$233M
Cap. Flow %
0.54%
Top 10 Hldgs %
25.87%
Holding
1,114
New
93
Increased
308
Reduced
456
Closed
92

Sector Composition

Rank Sector Weight
1 Technology 23.48%
2 Financials 15.88%
3 Healthcare 12.73%
4 Consumer Discretionary 9.7%
5 Industrials 8.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HGEN
1001
DELISTED
HUMANIGEN, INC.
HGEN
$174K ﹤0.01%
10,000
AGNC icon
1002
AGNC Investment
AGNC
$12.7B
$171K ﹤0.01%
10,112
-1,851
-15% -$32.9K
OCUL icon
1003
Ocular Therapeutix
OCUL
$1.85B
$171K ﹤0.01%
12,040
SHLX
1004
DELISTED
Shell Midstream Partners, L.P.
SHLX
$170K ﹤0.01%
+11,500
New +$172K
PAVM icon
1005
PAVmed
PAVM
$37.2M
$160K ﹤0.01%
56
-25
-31% -$59.1K
ATEC icon
1006
Alphatec Holdings
ATEC
$1.43B
$159K ﹤0.01%
10,404
+400
+4% +$6.17K
BDJ icon
1007
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.71B
$150K ﹤0.01%
14,792
+424
+3% +$4.26K
CNX icon
1008
CNX Resources
CNX
$4.8B
$149K ﹤0.01%
10,884
AIHS icon
1009
Senmiao Technology Ltd
AIHS
$20.4M
$146K ﹤0.01%
1,394
+614
+79% +$66K
OXLC
1010
Oxford Lane Capital
OXLC
$851M
$115K ﹤0.01%
3,100
-400
-11% -$14K
TCRT icon
1011
Alaunos Therapeutics
TCRT
$4.64M
$108K ﹤0.01%
272
ARYD
1012
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$107K ﹤0.01%
10,000
LSTA icon
1013
Lisata Therapeutics
LSTA
$11.9M
$89K ﹤0.01%
3,702
CRMD icon
1014
CorMedix
CRMD
$573M
$82K ﹤0.01%
12,000
PPT
1015
Franklin Premier Income Trust
PPT
$323M
$76K ﹤0.01%
16,304
+92
+0.6% +$433
EGIO
1016
DELISTED
Edgio, Inc. Common Stock
EGIO
$63K ﹤0.01%
500
SMTS
1017
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$52K ﹤0.01%
+17,135
New +$56.7K
DARE icon
1018
Dare Bioscience
DARE
$19.2M
$47K ﹤0.01%
2,083
SNT
1019
Senstar Technologies
SNT
$40.8M
$47K ﹤0.01%
10,000
SAIIW
1020
DELISTED
Software Acquisition Group Inc. II Warrant
SAIIW
$41K ﹤0.01%
+25,000
New +$43K
PTN
1021
Palatin Technologies
PTN
$13.4M
$35K ﹤0.01%
46
AAL icon
1022
American Airlines Group
AAL
$10.2B
-9,335
Closed -$223K
AEE icon
1023
Ameren
AEE
$31.4B
-2,482
Closed -$202K
AMBA icon
1024
Ambarella
AMBA
$3.03B
-9,353
Closed -$939K
ARWR icon
1025
Arrowhead Research
ARWR
$11.9B
-10,159
Closed -$674K

Similar funds

CIBC Private Wealth Group's Q2 2021 Portfolio in Review

As of Q2 2021, CIBC Private Wealth Group held 1,114 positions worth $43.5B, up 9.6% from $39.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

CIBC Private Wealth Group's Q2 2021 filing shows 93 new, 308 increased, 456 reduced and 92 closed positions. Its largest new stake was XPO: 1,654,372 shares worth $80M. The largest sale was Johnson & Johnson, an estimated $183M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • CIBC Private Wealth Group's largest Q2 2021 buy was XPO: 1,654,372 shares worth $80M.
  • CIBC Private Wealth Group added most to Martin Marietta Materials in Q2 2021, an estimated $189M increase.
  • CIBC Private Wealth Group's biggest Q2 2021 reduction was Johnson & Johnson, cutting an estimated $183M.
  • CIBC Private Wealth Group fully exited O-I Glass in Q2 2021, selling an estimated $23.4M.
  • CIBC Private Wealth Group's ten largest holdings make up 26% of its $43.5B portfolio in Q2 2021.
  • CIBC Private Wealth Group opened 93 new positions and closed 92 in Q2 2021.
  • CIBC Private Wealth Group's portfolio value rose 9.6% quarter-over-quarter to $43.5B.

Based on CIBC Private Wealth Group's 13F filing for Q2 2021, filed 16 Aug 2021.